This $2,282,687 federal Project Grant award from the National Cancer Institute under the Cancer Cause and Prevention Research Program (CFDA 93.393) will support a multi-year research effort to understand how different forms of care integration impact quality and outcomes for oncology patients. The project involves four interrelated studies examining integration across healthcare settings including health systems, independent oncology practices, post-acute/hospice care, and specialty pharmacies. The research aims to: 1) adapt a conceptual framework to describe key forms of integration beyond just structural/ownership changes; 2) measure and compare integration across settings and assess how different forms relate to structural features, practice factors, and market conditions; and 3) evaluate how integration is associated with utilization, spending, quality, and equitable care delivery. Harvard Medical School is leading this project, with Dana-Farber Cancer Institute serving as a sub-grantee focused on characterizing the integration of post-acute and hospice care into health systems. The findings are intended to inform policies and practices that can drive improvements in patient outcomes and experiences within the oncology care continuum.